Jul 7, 2023
JAMA Health Forum Editor John Ayanian, MD, MPP, and Associate
Editor Julie Donohue, PhD, speak with Aaron S. Kesselheim, MD, JD,
MPH, and Genevieve P. Kanter, PhD, about the role of advisory
committees convened by the US Food and Drug Administration (FDA) to
guide its decisions on whether to approve new prescription drugs.
They also consider how the FDA has responded to recommendations
from these advisory committees over the past decade.
Related Content: